Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2025-12-24 @ 3:35 PM
NCT ID:
NCT01037192
Eligibility Criteria:
Inclusion Criteria:
* Age 19 to 70 years
* Weight 40 - 80 kg
* Suspected or confirmed skin or soft tissue infection for which vancomycin is indicated
* Subject referred to or admitted into OPAT by an Infectious Disease Specialist or Emergency Physician
* Subject able to provide informed consent
Exclusion Criteria:
* Known history of allergy to vancomycin
* Pregnancy
* Granulocytopenia (\< 1x109/L)
* Renal impairment (serum creatinine \> 177 µmol/L or eGFR \< 50 mL/min)
* Known history of vestibular disease or hearing loss
* Subjects treated with vancomycin within the previous month
* Subjects who have received more than 24 hours of vancomycin
* Subjects receiving other antimicrobials that cover MRSA (e.g. cotrimoxazole, rifampin, linezolid)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
70 Years
Study:
NCT01037192
Study Brief:
Protocol Section:
NCT01037192